Sunday, February 07, 2016 10:05:27 AM
XXXX Saturday, XX/XX/13
Re: XXXXXX post# XXXXX
Post #
XXXXX
of XXXXXX Go
Take a look at the impressive resumes from team Lincoln Park Capital, compiling years of knowledge and experiences in a diversity of businesses and industries. They gave XXXXX Pharmaceuticals a thorough evaluation from their due diligence and liked our prospects and future outlook of ADT/ART and our business plan. They probably had access to proprietary information such as a tour of the FDA-DEA approved manufacturing facility in New Jersey. Team LPC has the qualifications to make these decisions with the conclusion that the risks on investing in XXXXX Pharmaceuticals would be worth the potential rewards. It's sure a peace-of-mind knowing that a high profile institutional investor share similar conclusions about
XXXXX as the little gal. Cheers!
Joshua B. ScheinfeldFounder and Managing Member
Mr. Scheinfeld was a founder and Managing Member of Fusion Capital, a Chicago based investment fund started in 1999 that has funded or committed to fund over $700 million. In addition, Mr. Scheinfeld is a serial entrepreneur and has extensive experience in starting, running and raising capital for public and private companies as well as real estate ventures. While a management consultant at McKinsey & Company, Inc., he was part of teams that solved business problems for Fortune 500 companies. Mr. Scheinfeld practiced law at the Chicago law firm of Katten Muchin Rosenman LLP where he specialized in corporate acquisition, securities and venture capital transactions. Mr. Scheinfeld received his Juris Doctor, Cum Laude, from Harvard Law School. Mr. Scheinfeld graduated Phi Beta Kappa with a BA in Economics and Distinction in all Subjects from Cornell University.
Jonathan I. CopeFounder and Managing Member
Mr. Cope was a principal at Fusion Capital, a Chicago based fund where he worked for approximately 10 years helping to manage the Funds investments with an emphasis primarily in life sciences and technology companies. While working at a captive firm for Equity Group Investments (a Sam Zell investment arm), Mr. Cope focused on M&A, private equity and securities matters. Mr. Cope also practiced law at Katten Muchin Rosenman LLP. Mr. Cope holds a Masters degree in Molecular Biology, a J.D. from the University of Chicago and is a Phi Beta Kappa, Summa Cum Laude graduate in Economics from Brandeis University. Mr. Cope is a co-founder of an elementary school based in Chicago, and has sat on the Board of several Chicago based non-profit organizations.
Dr. Michael BeaubaireChair, Scientific Advisory Board
Dr. Beaubaire leverages his clinical science, healthcare management experience, and financial transaction acumen in evaluating health care and general business investment opportunities for LPC. Prior to joining Lincoln Park Capital, Dr. Beaubaire has played significant roles advising emerging life science and device companies, healthcare service organizations, and interested institutional healthcare investors through his own advisory firm and affiliating with leading investment banks and strategic management consulting firms. Dr. Beaubaire earned his BS with Honors in Finance from the Wharton School, and his BA with Honors in Biological Basis of Behavior from the College of Arts & Sciences, both at the University of Pennsylvania. He received his Medical Doctorate degree from Northwestern University Medical School, and trained as an Internal Medicine resident at Evanston Northwestern Healthcare where he served as an educator to medical interns and students under his tutelage.
Richard C. Vogel CPAFounder and President
Mr. Vogel for twelve years has worked extensively on direct investments in the public equity markets. Mr. Vogel is also part of the Executive Management team of a Lincoln Park Capital portfolio company, Omnisure Group, LLC, a leading specialty finance company. As an investor, financial professional and Financial Operations Principal, Mr. Vogel has counseled for over 17 years various financial firms and members of the CBOE, CHX, FINRA, DTC and NSCC on the structuring of their operations and capital. Mr. Vogel also served as the CFO of Fusion Capital for ten years. He also has extensive experience with companies in various stages of their life cycle including startups and businesses in an active mode of expansion. Mr. Vogel is a CPA and FINRA Series 27 certified holding a BA with honors from Graham School of Management at Saint Xavier University. Mr. Vogel actively supports and serves several non-profit organizations based in West Michigan.
Robert A. GarciaFounder and Chief Financial Officer
Mr. Garcia brings a broad based knowledge of the private equity sector and public markets. Mr. Garcia also serves as the Controller of a Lincoln Park Capital portfolio company, Omnisure Group, LLC, a leading specialty finance company. As an investment professional, Mr. Garcia for twelve years has been involved in the operational side of private equity and portfolio management in the securities industry. Prior to joining Lincoln Park Capital, Mr. Garcia was with Fusion Capital for ten years handling all aspects of its operations. Mr. Garcia has worked for a boutique public accounting firm with extensive experience in the broker dealer and financial industries. Mr. Garcia earned a BS in Accounting from Indiana University's Kelley School of Business.
Phillip J. KerewichVice President
Mr. Kerewich contributes a unique background and understanding of the capital markets for public companies. Before joining Lincoln Park Capital, Mr. Kerewich was responsible for the client services, business development and transaction analysis for a research tool that is widely used by Placement Agents, Investors and Law Firms involved in private investments in public equities (PIPEs) called PrivateRaise, a service of DealFlow Media. Prior to which, he was a consultant to public companies assisting in capital raises, worked in the telecommunications industry and was a professional athlete. Mr. Kerewich earned a BA in Communications from The Ohio State University while being an active member in the Sigma Chi Fraternity and Captain of the Division I Mens Volleyball program.
Recent LWLG News
- Lightwave Logic Demonstrates Thought Leadership with Critical Contributions to Global Integrated Photonics Industry Roadmap • PR Newswire (US) • 04/16/2024 12:31:00 PM
- Lightwave Logic Secures New Patent for Diamondoid Non-linear Optical Chromophore Patent to Improves Material Robustness • PR Newswire (US) • 04/01/2024 12:31:00 PM
- Lightwave Logic EO Polymer Achieves World-Class Performance of 400Gbps with Plasmonic Mach Zehnder Modulator • PR Newswire (US) • 03/28/2024 12:31:00 PM
- Lightwave Logic Demonstrates World-Class 200Gbps Heterogeneous Polymer/Silicon Photonic Modulator Results • PR Newswire (US) • 03/25/2024 12:31:00 PM
- Lightwave Logic to Host Annual Meeting of Shareholders on May 22, 2024 • PR Newswire (US) • 03/19/2024 12:31:00 PM
- Lightwave Logic to Participate in Upcoming Investor Conferences • PR Newswire (US) • 03/15/2024 12:31:00 PM
- Lightwave Logic Provides Fourth Quarter and Fiscal Year 2023 Corporate Update • PR Newswire (US) • 03/01/2024 01:31:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 10:09:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:00:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/07/2023 12:11:28 AM
- Lightwave Logic Issues Shareholder Letter and Provides Corporate Update • PR Newswire (US) • 12/04/2023 01:31:00 PM
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Lightwave Logic Provides Third Quarter 2023 Corporate Update • PR Newswire (US) • 11/10/2023 01:31:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:24:23 PM
- Lightwave Logic to Participate in Upcoming Investor Conferences • PR Newswire (US) • 11/06/2023 01:31:00 PM
- Lightwave Logic CEO Dr. Michael Lebby to Present at the Optica Photonic-Enabled Cloud Computing Industry Summit • PR Newswire (US) • 10/12/2023 12:50:00 PM
- Lightwave Logic Receives 2023 Industry Innovation Award for Hybrid PIC/Optical Integration Platform at the European Conference on Optical Communications • PR Newswire (US) • 10/03/2023 12:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 08:00:08 PM
- Lightwave Logic to Participate in Upcoming Investor Conferences • PR Newswire (US) • 09/05/2023 12:31:00 PM
- Lightwave Logic Expands Its Colorado Operations to Support New Commercial Activities • PR Newswire (US) • 08/21/2023 12:31:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/10/2023 08:03:22 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/10/2023 08:01:26 PM
- Lightwave Logic Provides Second Quarter 2023 Corporate Update • PR Newswire (US) • 08/10/2023 12:31:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:56:47 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM